R-Lorcaserin Hydrochloride
Cat.No:IL2260 Solarbio
CAS:846589-98-8
Molecular Formula:C11H14ClN·HCl
Molecular Weight:232.15
Storage:Powder:2-8℃,2 years
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Neuronal Signal Pathway >
R-Lorcaserin HydrochlorideCAS:846589-98-8
Molecular Formula:C11H14ClN·HCl
Molecular Weight:232.15
Storage:Powder:2-8℃,2 years
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 846589-98-8 |
Name | R-Lorcaserin Hydrochloride |
Molecular Formula | C11H14ClN·HCl |
Molecular Weight | 232.15 |
Solubility | Soluble in --- |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years |
SMILES | CC1CNCCC2=C1C=C(C=C2)Cl.Cl |
InChIKey | ITIHHRMYZPNGRC-QRPNPIFTSA-N |
InChI | InChI=1S/C11H14ClN.ClH/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9;/h2-3,6,8,13H,4-5,7H2,1H3;1H/t8-;/m0./s1 |
PubChem CID | 11673085 |
Target Point | 5-HT Receptor |
Passage | Neuronal Signaling;GPCR & G Protein |
Background | Lorcaserin is a selective serotonin agonist. |
Biological Activity | R-Lorcaserin Hydrochloride 是一种5-HT(2C) 受体激动剂,具有治疗肥胖症的潜力。[1-2] |
Data Literature Source | [1]. Thomsen WJ,et al. Lorcaserin,a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther. 2008 May;325(2):577-87. [2]. Levin ED,et al. Lorcaserin,a 5-HT2C agonist,decreases nicotine self-administration in female rats. J Pharmacol Exp Ther. 2011 Sep;338(3):890-6. |
Unit | Bottle |
Specification | 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.